Neoantigens and genome instability: impact on immunogenomic phenotypes and immunotherapy response
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Neoantigens and genome instability: impact on immunogenomic phenotypes and immunotherapy response
Authors
Keywords
-
Journal
Genome Medicine
Volume 11, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-11-20
DOI
10.1186/s13073-019-0684-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Neoantigen-directed immune escape in lung cancer evolution
- (2019) Rachel Rosenthal et al. NATURE
- Genomic signatures predict the immunogenicity of BRCA-deficient breast cancer
- (2019) Adam A Kraya et al. CLINICAL CANCER RESEARCH
- Immunogenic neoantigens derived from gene fusions stimulate T cell responses
- (2019) Wei Yang et al. NATURE MEDICINE
- Immune evasion before tumour invasion in early lung squamous carcinogenesis
- (2019) Céline Mascaux et al. NATURE
- Pediatric patients with acute lymphoblastic leukemia generate abundant and functional neoantigen-specific CD8+ T cell responses
- (2019) Anthony E. Zamora et al. Science Translational Medicine
- Evolving neoantigen profiles in colorectal cancers with DNA repair defects
- (2019) Giuseppe Rospo et al. Genome Medicine
- Best practices for bioinformatic characterization of neoantigens for clinical utility
- (2019) Megan M. Richters et al. Genome Medicine
- MHC-II neoantigens shape tumour immunity and response to immunotherapy
- (2019) Elise Alspach et al. NATURE
- Somatic POLE exonuclease domain mutations are early events in sporadic endometrial and colorectal carcinogenesis, determining driver mutational landscape, clonal neoantigen burden and immune response
- (2018) Daniel Temko et al. JOURNAL OF PATHOLOGY
- The emerging clinical relevance of genomics in cancer medicine
- (2018) Michael F. Berger et al. Nature Reviews Clinical Oncology
- MHCflurry: Open-Source Class I MHC Binding Affinity Prediction
- (2018) Timothy J. O'Donnell et al. Cell Systems
- POLD1 and POLE Gene Mutations in Jewish Cohorts of Early-Onset Colorectal Cancer and of Multiple Colorectal Adenomas
- (2018) Guy Rosner et al. DISEASES OF THE COLON & RECTUM
- Combined analysis of antigen presentation and T cell recognition reveals restricted immune responses in melanoma
- (2018) Shelly Kalaora et al. Cancer Discovery
- Novel POLE pathogenic germline variant in a family with multiple primary tumors results in distinct mutational signatures
- (2018) Ester Castellsagué et al. HUMAN MUTATION
- Immunogenomic analyses associate immunological alterations with mismatch repair defects in prostate cancer
- (2018) Daniel Nava Rodrigues et al. JOURNAL OF CLINICAL INVESTIGATION
- Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
- (2018) Derin B. Keskin et al. NATURE
- Deep learning using tumor HLA peptide mass spectrometry datasets improves neoantigen identification
- (2018) Brendan Bulik-Sullivan et al. NATURE BIOTECHNOLOGY
- Immune checkpoint blockade resistance-related B2M hotspot mutations in microsatellite-unstable colorectal carcinoma
- (2018) Su Yeon Yeon et al. PATHOLOGY RESEARCH AND PRACTICE
- Noncoding regions are the main source of targetable tumor-specific antigens
- (2018) Céline M. Laumont et al. Science Translational Medicine
- Mutation patterns in genes encoding interferon signaling and antigen presentation: A pan-cancer survey with implications for the use of immune checkpoint inhibitors
- (2017) Jan Budczies et al. GENES CHROMOSOMES & CANCER
- Risk of colorectal cancer for carriers of a germ-line mutation in POLE or POLD1
- (2017) Daniel D Buchanan et al. GENETICS IN MEDICINE
- Randomized, Double-Blind, Phase III Trial of Ipilimumab Versus Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naive Castration-Resistant Prostate Cancer
- (2017) Tomasz M. Beer et al. JOURNAL OF CLINICAL ONCOLOGY
- Characterization of a novel POLD1 missense founder mutation in a Spanish population
- (2017) Rosario Ferrer-Avargues et al. JOURNAL OF GENE MEDICINE
- Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis
- (2017) Samra Turajlic et al. LANCET ONCOLOGY
- Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth
- (2017) Giovanni Germano et al. NATURE
- Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
- (2017) Ugur Sahin et al. NATURE
- An immunogenic personal neoantigen vaccine for patients with melanoma
- (2017) Patrick A. Ott et al. NATURE
- HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures
- (2017) Helen Davies et al. NATURE MEDICINE
- Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
- (2017) Dung T. Le et al. SCIENCE
- Resistance to checkpoint blockade therapy through inactivation of antigen presentation
- (2017) Moshe Sade-Feldman et al. Nature Communications
- A molecular portrait of microsatellite instability across multiple cancers
- (2017) Isidro Cortes-Ciriano et al. Nature Communications
- POLE and POLD1 screening in 155 patients with multiple polyps and early-onset colorectal cancer
- (2017) Clara Esteban-Jurado et al. Oncotarget
- Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade
- (2017) Pornpimol Charoentong et al. Cell Reports
- Multilevel genomics of colorectal cancers with microsatellite instability—clinical impact of JAK1 mutations and consensus molecular subtype 1
- (2017) Anita Sveen et al. Genome Medicine
- Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden
- (2017) Zachary R. Chalmers et al. Genome Medicine
- Prevalence and Spectrum of Germline Cancer Susceptibility Gene Mutations Among Patients With Early-Onset Colorectal Cancer
- (2017) Rachel Pearlman et al. JAMA Oncology
- Prevalence and Penetrance of Major Genes and Polygenes for Colorectal Cancer
- (2016) Aung Ko Win et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- A novel germline POLE mutation causes an early onset cancer prone syndrome mimicking constitutional mismatch repair deficiency
- (2016) Katharina Wimmer et al. Familial Cancer
- Integrative Analyses of Colorectal Cancer Show Immunoscore Is a Stronger Predictor of Patient Survival Than Microsatellite Instability
- (2016) Bernhard Mlecnik et al. IMMUNITY
- Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency
- (2016) Eric Bouffet et al. JOURNAL OF CLINICAL ONCOLOGY
- Reliable Detection of Mismatch Repair Deficiency in Colorectal Cancers Using Mutational Load in Next-Generation Sequencing Panels
- (2016) Zsofia K. Stadler et al. JOURNAL OF CLINICAL ONCOLOGY
- Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma
- (2016) Jesse M. Zaretsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
- (2016) N. McGranahan et al. SCIENCE
- Immunogenomics of Hypermutated Glioblastoma: A Patient with Germline POLE Deficiency Treated with Checkpoint Blockade Immunotherapy
- (2016) T. M. Johanns et al. Cancer Discovery
- Methylation of RAD51B, XRCC3 and other homologous recombination genes is associated with expression of immune checkpoints and an inflammatory signature in squamous cell carcinoma of the head and neck, lung and cervix
- (2016) Damian T. Rieke et al. Oncotarget
- pVAC-Seq: A genome-guided in silico approach to identifying tumor neoantigens
- (2016) Jasreet Hundal et al. Genome Medicine
- Long-term Response to Nivolumab and Acute Renal Failure in a Patient with Metastatic Papillary Renal Cell Carcinoma and a PD-L1 Tumor Expression Increased with Sunitinib Therapy: A Case Report
- (2016) Juan Ruiz-Bañobre et al. Frontiers in Oncology
- Anti-programmed Cell Death Protein 1 (PD-1) Antibody Nivolumab Leads to a Dramatic and Rapid Response in Papillary Renal Cell Carcinoma with Sarcomatoid and Rhabdoid Features
- (2015) Daniel M. Geynisman EUROPEAN UROLOGY
- A novel POLE mutation associated with cancers of colon, pancreas, ovaries and small intestine
- (2015) Maren F. Hansen et al. Familial Cancer
- Tumor neoantigens: building a framework for personalized cancer immunotherapy
- (2015) Matthew M. Gubin et al. JOURNAL OF CLINICAL INVESTIGATION
- Comprehensive analysis of cancer-associated somatic mutations in class I HLA genes
- (2015) Sachet A Shukla et al. NATURE BIOTECHNOLOGY
- Combined hereditary and somatic mutations of replication error repair genes result in rapid onset of ultra-hypermutated cancers
- (2015) Adam Shlien et al. NATURE GENETICS
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
- (2015) Dung T. Le et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genomic correlates of response to CTLA-4 blockade in metastatic melanoma
- (2015) E. M. Van Allen et al. SCIENCE
- A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells
- (2015) B. M. Carreno et al. SCIENCE
- Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
- (2015) N. A. Rizvi et al. SCIENCE
- The future of immune checkpoint therapy
- (2015) P. Sharma et al. SCIENCE
- OptiType: precision HLA typing from next-generation sequencing data
- (2014) András Szolek et al. BIOINFORMATICS
- Polymerase ɛ (POLE) mutations in endometrial cancer: Clinical outcomes and implications for Lynch syndrome testing
- (2014) Caroline C. Billingsley et al. CANCER
- A Common Cancer-Associated DNA Polymerase Mutation Causes an Exceptionally Strong Mutator Phenotype, Indicating Fidelity Defects Distinct from Loss of Proofreading
- (2014) D. P. Kane et al. CANCER RESEARCH
- DNA polymerase ε and its roles in genome stability
- (2014) Erin E. Henninger et al. IUBMB LIFE
- Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial
- (2014) Eugene D Kwon et al. LANCET ONCOLOGY
- Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
- (2014) Matthew M. Gubin et al. NATURE
- Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
- (2014) Alexandra Snyder et al. NEW ENGLAND JOURNAL OF MEDICINE
- Signatures of mutational processes in human cancer
- (2013) Ludmil B. Alexandrov et al. NATURE
- Mutated BCR-ABL Generates Immunogenic T-cell Epitopes in CML Patients
- (2012) A. Cai et al. CLINICAL CANCER RESEARCH
- Relevance, Pathogenesis, and Testing Algorithm for Mismatch Repair–Defective Colorectal Carcinomas
- (2012) William K. Funkhouser et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Tandem duplication of chromosomal segments is common in ovarian and breast cancer genomes
- (2012) David J McBride et al. JOURNAL OF PATHOLOGY
- Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting
- (2012) Hirokazu Matsushita et al. NATURE
- Inherited Colorectal Cancer Syndromes
- (2011) Fay Kastrinos et al. CANCER JOURNAL
- Constitutional mismatch repair-deficiency syndrome
- (2010) K. Wimmer et al. HAEMATOLOGICA
- Mutator phenotypes due to DNA replication infidelity
- (2010) Mercedes E. Arana et al. SEMINARS IN CANCER BIOLOGY
- Immune Response Against Frameshift-Induced Neopeptides in HNPCC Patients and Healthy HNPCC Mutation Carriers
- (2008) Yvette Schwitalle et al. GASTROENTEROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started